These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1603880)

  • 1. Peripheral markers of serotonin and dopamine function in obsessive-compulsive disorder.
    Marazziti D; Hollander E; Lensi P; Ravagli S; Cassano GB
    Psychiatry Res; 1992 Apr; 42(1):41-51. PubMed ID: 1603880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet 3H-imipramine binding sites in obsessive-compulsive behavior.
    Kim SW; Dysken MW; Pandey GN; Davis JM
    Biol Psychiatry; 1991 Sep; 30(5):467-74. PubMed ID: 1657222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin uptake and imipramine binding in the blood platelets of obsessive-compulsive disorder patients.
    Bastani B; Arora RC; Meltzer HY
    Biol Psychiatry; 1991 Jul; 30(2):131-9. PubMed ID: 1655071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients.
    Weizman A; Carmi M; Hermesh H; Shahar A; Apter A; Tyano S; Rehavi M
    Am J Psychiatry; 1986 Mar; 143(3):335-9. PubMed ID: 3006522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased platelet imipramine binding in Tourette syndrome children with obsessive-compulsive disorder.
    Weizman A; Mandel A; Barber Y; Weitz R; Cohen A; Mester R; Rehavi M
    Biol Psychiatry; 1992 Apr; 31(7):705-11. PubMed ID: 1318082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet imipramine binding and serotonin uptake in obsessive-compulsive patients.
    Vitiello B; Shimon H; Behar D; Stoff D; Bridger WH; Friedman E
    Acta Psychiatr Scand; 1991 Jul; 84(1):29-32. PubMed ID: 1927563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet 3H-imipramine binding and sulphotransferase activity in primary headache.
    Marazziti D; Bonuccelli U; Nuti A; Toni C; Pedri S; Palego L; Pavese N; Lucetti C; Muratorio A; Cassano GB
    Cephalalgia; 1994 Jun; 14(3):210-4. PubMed ID: 7954741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet markers in suicide attempters.
    Marazziti D; Presta S; Silvestri S; Battistini A; Mosti L; Balestri C; Palego L; Conti L
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 May; 19(3):375-83. PubMed ID: 7624489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in platelet markers of obsessive-compulsive patients during a double-blind trial of fluvoxamine versus clomipramine.
    Marazziti D; Pfanner C; Palego L; Gemignani A; Milanfranchi A; Ravagli S; Lensi P; Presta S; Cassano GB
    Pharmacopsychiatry; 1997 Nov; 30(6):245-9. PubMed ID: 9442546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology.
    Zohar J; Insel TR
    Biol Psychiatry; 1987 Jun; 22(6):667-87. PubMed ID: 3036259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased platelet 3H-paroxetine binding in obsessive-compulsive patients.
    Marazziti D; Rossi A; Gemignani A; Giannaccini G; Pfanner C; Milanfranchi A; Presta S; Lucacchini A; Cassano GB
    Neuropsychobiology; 1996; 34(4):184-7. PubMed ID: 9121618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet serotonergic markers as endophenotypes for obsessive-compulsive disorder.
    Delorme R; Betancur C; Callebert J; Chabane N; Laplanche JL; Mouren-Simeoni MC; Launay JM; Leboyer M
    Neuropsychopharmacology; 2005 Aug; 30(8):1539-47. PubMed ID: 15886722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A test of the tridimensional personality theory: association with diagnosis and platelet imipramine binding in obsessive-compulsive disorder.
    Pfohl B; Black D; Noyes R; Kelley M; Blum N
    Biol Psychiatry; 1990 Jul; 28(1):41-6. PubMed ID: 2165423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychopathology and personality characteristics in relation to blood serotonin in Tourette's syndrome and obsessive-compulsive disorder.
    Cath DC; Spinhoven P; Landman AD; van Kempen GM
    J Psychopharmacol; 2001 Jun; 15(2):111-9. PubMed ID: 11448084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder?
    Goodman WK; McDougle CJ; Price LH; Riddle MA; Pauls DL; Leckman JF
    J Clin Psychiatry; 1990 Aug; 51 Suppl():36-43; discussion 55-8. PubMed ID: 2199433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurobiology of obsessive compulsive disorder: a possible role for serotonin.
    Winslow JT; Insel TR
    J Clin Psychiatry; 1990 Aug; 51 Suppl():27-31; discussion 55-8. PubMed ID: 2199432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The serotonin hypothesis of obsessive compulsive disorder.
    Barr LC; Goodman WK; Price LH
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():79-82. PubMed ID: 8201248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tritiated imipramine binding in obsessive-compulsive volunteers and psychiatrically normal controls.
    Black DW; Kelly M; Myers C; Noyes R
    Biol Psychiatry; 1990 Feb; 27(3):319-27. PubMed ID: 2154266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder.
    Koo MS; Kim EJ; Roh D; Kim CH
    Expert Rev Neurother; 2010 Feb; 10(2):275-90. PubMed ID: 20136383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet [3H]paroxetine binding in patients with OCD-related disorders.
    Marazziti D; Dell'Osso L; Presta S; Pfanner C; Rossi A; Masala I; Baroni S; Giannaccini G; Lucacchini A; Cassano GB
    Psychiatry Res; 1999 Dec; 89(3):223-8. PubMed ID: 10708268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.